281 related articles for article (PubMed ID: 7548733)
41. Formation and reactivity of alternative quinone methides from butylated hydroxytoluene: possible explanation for species-specific pneumotoxicity.
Bolton JL; Sevestre H; Ibe BO; Thompson JA
Chem Res Toxicol; 1990; 3(1):65-70. PubMed ID: 2131827
[TBL] [Abstract][Full Text] [Related]
42. Quenching of quercetin quinone/quinone methides by different thiolate scavengers: stability and reversibility of conjugate formation.
Awad HM; Boersma MG; Boeren S; Van Bladeren PJ; Vervoort J; Rietjens IM
Chem Res Toxicol; 2003 Jul; 16(7):822-31. PubMed ID: 12870884
[TBL] [Abstract][Full Text] [Related]
43. Formation and biological targets of botanical o-quinones.
Bolton JL; Dunlap TL; Dietz BM
Food Chem Toxicol; 2018 Oct; 120():700-707. PubMed ID: 30063944
[TBL] [Abstract][Full Text] [Related]
44. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.
Kassahun K; Pearson PG; Tang W; McIntosh I; Leung K; Elmore C; Dean D; Wang R; Doss G; Baillie TA
Chem Res Toxicol; 2001 Jan; 14(1):62-70. PubMed ID: 11170509
[TBL] [Abstract][Full Text] [Related]
45. Alkylation of 2'-deoxynucleosides and DNA by quinone methides derived from 2,6-di-tert-butyl-4-methylphenol.
Lewis MA; Yoerg DG; Bolton JL; Thompson JA
Chem Res Toxicol; 1996 Dec; 9(8):1368-74. PubMed ID: 8951242
[TBL] [Abstract][Full Text] [Related]
46. Catechol formation: a novel pathway in the metabolism of sterigmatocystin and 11-methoxysterigmatocystin.
Pfeiffer E; Fleck SC; Metzler M
Chem Res Toxicol; 2014 Dec; 27(12):2093-9. PubMed ID: 25380456
[TBL] [Abstract][Full Text] [Related]
47. Metabolism of caffeic acid by isolated rat hepatocytes and subcellular fractions.
Moridani MY; Scobie H; O'Brien PJ
Toxicol Lett; 2002 Jul; 133(2-3):141-51. PubMed ID: 12119122
[TBL] [Abstract][Full Text] [Related]
48. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
[TBL] [Abstract][Full Text] [Related]
49. Bioactivation of sitaxentan in liver microsomes, hepatocytes, and expressed human P450s with characterization of the glutathione conjugate by liquid chromatography tandem mass spectrometry.
Erve JC; Gauby S; Maynard JW; Svensson MA; Tonn G; Quinn KP
Chem Res Toxicol; 2013 Jun; 26(6):926-36. PubMed ID: 23721565
[TBL] [Abstract][Full Text] [Related]
50. Quinone methide formation from para isomers of methylphenol (cresol), ethylphenol, and isopropylphenol: relationship to toxicity.
Thompson DC; Perera K; London R
Chem Res Toxicol; 1995; 8(1):55-60. PubMed ID: 7703367
[TBL] [Abstract][Full Text] [Related]
51. Metabolic activation of 3-hydroxyanisole by isolated rat hepatocytes.
Moridani MY; Cheon SS; Khan S; O'Brien PJ
Chem Biol Interact; 2003 Jan; 142(3):317-33. PubMed ID: 12453669
[TBL] [Abstract][Full Text] [Related]
52. 17 beta-estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation.
Butterworth M; Lau SS; Monks TJ
Chem Res Toxicol; 1996 Jun; 9(4):793-9. PubMed ID: 8831825
[TBL] [Abstract][Full Text] [Related]
53. Sequential metabolism and bioactivation of the hepatotoxin benzbromarone: formation of glutathione adducts from a catechol intermediate.
McDonald MG; Rettie AE
Chem Res Toxicol; 2007 Dec; 20(12):1833-42. PubMed ID: 18020424
[TBL] [Abstract][Full Text] [Related]
54. Formation of glutathione conjugates during oxidation of eugenol by microsomal fractions of rat liver and lung.
Thompson D; Constantin-Teodosiu D; Egestad B; Mickos H; Moldéus P
Biochem Pharmacol; 1990 May; 39(10):1587-95. PubMed ID: 2337416
[TBL] [Abstract][Full Text] [Related]
55. Oxidation of 3,4-dihydroxybenzylamine affords 3,4-dihydroxybenzaldehyde via the quinone methide intermediate.
Sugumaran M
Pigment Cell Res; 1995 Oct; 8(5):250-4. PubMed ID: 8789199
[TBL] [Abstract][Full Text] [Related]
56. Quinone methide as a reactive intermediate formed during the biosynthesis of papiliochrome II, a yellow wing pigment of papilionid butterflies.
Saul SJ; Sugumaran M
FEBS Lett; 1991 Feb; 279(1):145-8. PubMed ID: 1995334
[TBL] [Abstract][Full Text] [Related]
57. Detection and characterization of a glutathione conjugate of ochratoxin A.
Dai J; Park G; Wright MW; Adams M; Akman SA; Manderville RA
Chem Res Toxicol; 2002 Dec; 15(12):1581-8. PubMed ID: 12482240
[TBL] [Abstract][Full Text] [Related]
58. Bioactivation of 4-methylphenol (p-cresol) via cytochrome P450-mediated aromatic oxidation in human liver microsomes.
Yan Z; Zhong HM; Maher N; Torres R; Leo GC; Caldwell GW; Huebert N
Drug Metab Dispos; 2005 Dec; 33(12):1867-76. PubMed ID: 16174805
[TBL] [Abstract][Full Text] [Related]
59. Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome p450s.
Damsten MC; de Vlieger JS; Niessen WM; Irth H; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2008 Nov; 21(11):2181-7. PubMed ID: 18816075
[TBL] [Abstract][Full Text] [Related]
60. Identification of quinone methide metabolites of dauricine in human liver microsomes and in rat bile.
Wang Y; Zhong D; Chen X; Zheng J
Chem Res Toxicol; 2009 May; 22(5):824-34. PubMed ID: 19358519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
